These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32953152)

  • 1. Integrative bioinformatics analysis of prognostic alternative splicing signatures in gastric cancer.
    Zong Z; Li H; Ning Z; Hu C; Tang F; Zhu X; Tian H; Zhou T; Wang H
    J Gastrointest Oncol; 2020 Aug; 11(4):685-694. PubMed ID: 32953152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic alternative splicing signature in gastric cancer.
    Wang Z; Wu Q; Liu Y; Li Q; Li J
    Arch Public Health; 2022 May; 80(1):145. PubMed ID: 35614517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
    Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
    Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma.
    Yang C; Wu Q; Huang K; Wang X; Yu T; Liao X; Huang J; Zhu G; Gong Y; Han C; Su H; Qin W; Peng T
    Front Oncol; 2019; 9():511. PubMed ID: 31275849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
    Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
    Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
    DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer.
    Wei C; Xie W; Huang X; Mo X; Liu Z; Wu G; Meng Y; Jeen F; Ge L; Zhang L; Liao L; Liu J; Tang W
    J Cancer; 2021; 12(10):2982-2992. PubMed ID: 33854599
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of alternative splicing events and prognostic signatures in breast cancer.
    Han P; Zhu J; Feng G; Wang Z; Ding Y
    BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
    Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
    Front Immunol; 2021; 12():719628. PubMed ID: 34413861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
    Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
    Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic profiling of alternative splicing in
    Liu C; Hu C; Li Z; Feng J; Huang J; Yang B; Wen T
    Cancer Cell Int; 2020; 20():279. PubMed ID: 32617077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
    Zhang D; Duan Y; Wang Z; Lin J
    Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Analyses of the Differentially Expressed Alternative Splicing Events in Gastric Cancer and Its Clinical Significance.
    Lin C; Yu B; Zhang M; Chen Y; Li L; Zhao D
    Front Genet; 2020; 11():522831. PubMed ID: 33281863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune signature profiling identified prognostic factors for gastric cancer.
    Yang W; Lai Z; Li Y; Mu J; Yang M; Xie J; Xu J
    Chin J Cancer Res; 2019 Jun; 31(3):463-470. PubMed ID: 31354215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer.
    Xu L; Pan J; Ding Y; Pan H
    Front Genet; 2020; 11():522383. PubMed ID: 33193606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of alternative splicing events in head and neck squamous cell carcinoma.
    Ding Y; Feng G; Yang M
    Cancer Cell Int; 2020; 20():168. PubMed ID: 32467664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation signatures associated with prognosis of gastric cancer.
    Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
    BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing data.
    Zhang Y; Ma S; Niu Q; Han Y; Liu X; Jiang J; Chen S; Lin H
    BMC Genomics; 2020 Aug; 21(1):580. PubMed ID: 32831016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.